356sek
-4,0 %
Date:2025-08-01Time:18:00:00Latest report:Q1-2025List:First NorthTicker:ACOU
Market Cap:75 msekEnterprise Value:72 msekNet Sales:4,97 msekEarnings:-15,4 msekEmployees:0ISIN:SE0009189608

Ratios

10-year key figure history for AcouSort turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for AcouSort with index and moving average MA50 and MA200.

Stockprice:3,56
MA50:3,33
MA200:7,24
Price/MA200:-50,8 %
RSI (14):56,6
Price/MA50:6,9 %

Description

AcouSort operates in the medical technology sector. The company has a developed platform technology focused on acoustophoresis, which uses ultrasound to separate and analyze the compositions of biological cells. The technology is mainly used in the analysis of cancer cases and sepsis (blood poisoning). A large part of the research is carried out in collaboration with other players in Life Science. The company was established in 2010 and has its headquarters in Lund.

Biotechnology